Tag Archive > Metastatic Cancer

Verbesserung der Ergebnisse bei der Behandlung und Kontrolle von metastasierendem Dickdarm- und Enddarmkrebs – Internationales Weißbuch auf dem Europäischen Krebskongress 2013 veröffentlicht

Amsterdam (ots/PRNewswire) – Die Angiogenesis Foundation veröffentlichte am Europäischen Krebskongress 2013 ein Weißbuch, das sich mit den Erfordernissen, den Herausforderungen und den vorgeschlagenen Lösungen zur Verbesserung der Behandlung von metastasierendem Dickdarm- und Enddarmkrebs (mCRC) beschäftigt, der weltweit unter Männern am dritthäufigsten und unter Frauen am zweithäufigsten auftretenden Krebsart. Das Weißbuch mit dem Titel “Improving Outcomes […]

Continue reading

, , , , , , , , ,

Eisai Expands in Israeli Market With Approval of Halaven

Hatfield, England (ots/PRNewswire) – Metastatic breast cancer treatment Halaven(R) (eribulin) provides a statistically significant overall survival benefit for women with the disease Halaven(R) (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease, has recently received registration approval from the […]

Continue reading

, , , , , , , , ,

Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting

Hatfield, England (ots/PRNewswire) – Eisai announced today that 12 abstracts highlighting new study results will be presented during the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicago, USA, from 1-5 June 2012. These studies highlight Eisai’s current product portfolio and oncology pipeline, reinforcing the company’s commitment to patients […]

Continue reading

, , , , , , , , ,

German Federal Regulator Confirms Additional Benefit of eribulin for Metastatic or Locally Advanced Breast Cancer

Frankfurt And Hatfield, England (ots/PRNewswire) – ? The German Federal Joint Committee (G-BA), the supreme decision-making body of the self-governing medical system in Germany, announced that it considers the use of Halaven(R) (eribulin) to have additional benefit versus comparative treatments, defined by the G-BA for women who have already had extensive prior treatment of metastatic […]

Continue reading

, , , , , , ,

Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer

Thousand Oaks, California (ots/PRNewswire) – Amgen today issued the following statement: Amgen has received notice that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for Amgen’s application to extend the marketing authorization in Europe for Vectibix(R) (panitumumab) to include combination with chemotherapy for […]

Continue reading

, , , , , , , , , , , , , , ,

Avastin Plus Commonly Used Chemotherapies Improves the Time Breast Cancer Patients Live Without Their Disease Getting Worse

Basel, Switzerland (ots/PRNewswire) – – RIBBON-1 Study Confirms Benefit of Avastin in Treating HER2-Negative Breast Cancer – For Non-US, Non-UK and Non-Austrian Media Results from the phase III RIBBON-1 study presented today at ASCO showed that patients with advanced HER2-negative breast cancer who were treated with Avastin(R) (bevacizumab) plus the most commonly used chemotherapies lived […]

Continue reading

, , , , , , , , , , , ,